Debt to Equity Ratio Chart

View Debt to Equity Ratio for RMHI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Debt to Equity Ratio Data

View and export this data back to 2008. Start Trial.
Date Value
June 30, 2026 -0.0871
March 31, 2026 -0.0914
December 31, 2025 -0.1027
September 30, 2025 -0.098
June 30, 2025 -0.1109
March 31, 2025 -0.1039
December 31, 2024 -0.1098
September 30, 2024 -0.1138
June 30, 2024 -0.1219
March 31, 2024 -0.1506
December 31, 2023 -0.1318
September 30, 2023 -0.1276
June 30, 2023 -0.1094
December 31, 2022 -0.4524
September 30, 2022 -0.5558
June 30, 2022 -0.633
March 31, 2022 -0.6998
December 31, 2021 -0.799
September 30, 2021 -1.036
June 30, 2021 -0.3303
March 31, 2021 -0.2099
December 31, 2020 -0.262
September 30, 2020 -0.2519
June 30, 2020 -0.2564
March 31, 2020 -0.2602
Date Value
December 31, 2019 -0.264
September 30, 2019 -0.268
June 30, 2019 -0.2725
March 31, 2019 -0.2768
December 31, 2018 -0.2812
September 30, 2018 -0.2849
June 30, 2018 -0.3176
March 31, 2018 -0.2289
December 31, 2017 -0.1248
September 30, 2017 -0.1297
June 30, 2017 -0.1485
March 31, 2017 -0.1625
December 31, 2016 0.00
September 30, 2016 0.00
June 30, 2016 0.00
March 31, 2016 0.00
December 31, 2015 0.00
June 30, 2015 0.00
March 31, 2015 0.00
December 31, 2014 0.00
September 30, 2014 0.00
June 30, 2014 0.00
March 31, 2014 -1.140
December 31, 2013 -1.845
September 30, 2013 0.00

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
Biotricity, Inc. -0.7993
Aclarion, Inc. 0.00
HeartFlow, Inc. 0.097
Agilent Technologies, Inc. 0.5363
Abbott Laboratories 0.638